Key result
Editorial outlines rationale for trials testing risk-factor reduction in high-risk type 2 diabetes.
Patients with type 2 diabetes mellitus without a history of myocardial infarction have the same risk of a coronary event as patients without diabetes who do have a history of myocardial infarction.1 This observation was part of the basis for the recommendation by the Adult Treatment Panel III (ATP III) of the National Cholesterol Education Program that diabetes should be considered a “coronary heart disease risk equivalent” and a target for aggressive reduction of risk factors.2 It has also contributed to the rationale for randomized clinical trials to evaluate the effects of risk-factor reduction in such high-risk patients.The Action . . .
No takes yet. Share an insight, caveat, or question.
Peter M. Nilsson (2010) conducted an editorial in Type 2 diabetes mellitus. Risk-factor reduction was evaluated. This editorial discusses the rationale for randomized clinical trials evaluating the effects of risk-factor reduction in high-risk patients with type 2 diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: